WCMNY
INBX icon

Westchester Capital Management (New York)’s Inhibrx INBX Stock Holding History

Westchester Capital Management (New York)’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-64,339
Closed -$912K – 204
2024
Q2 		$912K Buy
+64,339
New +$1.01M 0.03% 144

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Slotnik Capital Dallas, Texas $342M AUM 105.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Westchester Capital Management (New York)'s INBX Position: Q3 2024 in Review

Westchester Capital Management (New York) sold out of Inhibrx (INBX) in Q3 2024, closing a stake of 64,339 shares — an estimated $912K sold.

Westchester Capital Management (New York) first reported a position in INBX in Q2 2024 and held it in 1 quarter. The position peaked at $912K in Q2 2024. 96 funds tracked by Wall St. Rank hold INBX as of Q3 2024.

  • Westchester Capital Management (New York) reported no remaining Inhibrx position as of Q3 2024 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 64,339 Inhibrx shares in Q3 2024, an estimated $912K.
  • Westchester Capital Management (New York) first reported a position in Inhibrx in Q2 2024 and held it in 1 quarter.
  • Westchester Capital Management (New York)'s Inhibrx position peaked at $912K in Q2 2024.
  • 96 funds tracked by Wall St. Rank held Inhibrx as of Q3 2024.

Based on Westchester Capital Management (New York)'s 13F filing for Q3 2024, filed 14 Nov 2024.